share_log

Phathom Pharmaceuticals(PHAT.US)获Stifel首次覆盖,给予买入评级, 目标价24.00美元。

Zhitong Finance ·  May 3 05:55

Phathom Pharmaceuticals(PHAT.US)获Stifel首次覆盖,给予买入评级, 目标价24.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment